[[File:Rational harm assessment of drugs radar plot.svg|thumb|Addiction experts in psychiatry, chemistry, pharmacology, forensic science, epidemiology, and the police and legal services engaged in [[Delphi method|delphic analysis]] regarding 20 popular recreational drugs. 4-MTA was ranked 12th in dependence, 10th in physical harm, and 17th in social harm.<ref>{{cite journal|last1=Nutt|first1=D|last2=King|first2=LA|last3=Saulsbury|first3=W|last4=Blakemore|first4=C|title=Development of a rational scale to assess the harm of drugs of potential misuse.|journal=Lancet|date=24 March 2007|volume=369|issue=9566|pages=1047–53|pmid=17382831|doi=10.1016/s0140-6736(07)60464-4}}</ref>]]

 
4-MTA is a strong serotonin releaser similar to [[paramethoxyamphetamine]] (PMA), which can cause pronounced [[hyperthermia]] potentially resulting in organ failure and death.<ref>{{cite journal | last1 = Elliott | first1 = SP | title = Fatal poisoning with a new phenylethylamine: 4-methylthioamphetamine (4-MTA) | journal = Journal of analytical toxicology | volume = 24 | issue = 2 | pages = 85–89 | year = 2000 | pmid = 10732944 | doi=10.1093/jat/24.2.85}}</ref><ref>{{cite journal | last1 = De Letter | first1 = EA | last2 = Coopman | first2 = VA | last3 = Cordonnier | first3 = JA | last4 = Piette | first4 = MH | title = One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings | journal = International journal of legal medicine | volume = 114 | issue = 6 | pages = 352–6 | year = 2001 | pmid = 11508803 | doi=10.1007/s004140100204}}</ref><ref>{{cite journal | last1 = Decaestecker | first1 = T | last2 = De Letter | first2 = E | last3 = Clauwaert | first3 = K | last4 = Bouche | first4 = MP | last5 = Lambert | first5 = W | last6 = Van Bocxlaer | first6 = J | last7 = Piette | first7 = M | last8 = Van Den Eeckhout | first8 = E | last9 = Van Peteghem | first9 = C | last10 = De Leenheer | first10 = A | title = Fatal 4-MTA intoxication: development of a liquid chromatographic-tandem mass spectrometric assay for multiple matrices | journal = Journal of analytical toxicology | volume = 25 | issue = 8 | pages = 705–10 | year = 2001 | pmid = 11765028 | doi=10.1093/jat/25.8.705}}</ref><ref>{{cite journal | last1 = Smets | first1 = G | last2 = Bronselaer | first2 = K | last3 = De Munnynck | first3 = K | last4 = De Feyter | first4 = K | last5 = Van De Voorde | first5 = W | last6 = Sabbe | first6 = M | title = Amphetamine toxicity in the emergency department | journal = European Journal of Emergency Medicine | volume = 12 | issue = 4 | pages = 193–7 | year = 2005 | pmid = 16034267 | doi = 10.1097/00063110-200508000-00010 }}</ref> The subjective effects of 4-MTA include prolonged stimulation, which, in contrast to other [[amphetamine]]s, is accompanied by little sense of [[euphoria]].<ref>[https://www.erowid.org/experiences/exp.php?ID=83154 Erowid experience report on 4-MTA (experience year: 2001)]</ref> 4-MTA is also an [[MAO-A]] inhibitor, which may explain its tendency to easily cause adverse effects, as [[MAOI]]s are not considered safe to use in conjunction with stimulants.<ref>{{cite journal | last1 = Carmo | first1 = H | last2 = Remião | first2 = F | last3 = Carvalho | first3 = F | last4 = Fernandes | first4 = E | last5 = De Boer | first5 = D | last6 = Dos Reys | first6 = LA | last7 = De Lourdes Bastos | first7 = M | title = 4-Methylthioamphetamine-induced hyperthermia in mice: influence of serotonergic and catecholaminergic pathways | journal = [[Toxicology and applied pharmacology]] | volume = 190 | issue = 3 | pages = 262–71 | year = 2003 | pmid = 12902197 | doi=10.1016/S0041-008X(03)00190-X}}</ref><ref>{{cite journal | last1 = Hurtado-Guzmán | first1 = C | last2 = Fierro | first2 = A | last3 = Iturriaga-Vásquez | first3 = P | last4 = Sepúlveda-Boza | first4 = S | last5 = Cassels | first5 = BK | last6 = Reyes-Parada | first6 = M | title = Monoamine oxidase inhibitory properties of optical isomers and N-substituted derivatives of 4-methylthioamphetamine | journal = [[Journal of enzyme inhibition and medicinal chemistry]] | volume = 18 | issue = 4 | pages = 339–47 | year = 2003 | pmid = 14567549 | doi = 10.1080/1475636031000118437 }}</ref><ref>{{Cite journal | last1 = Carmo | first1 = H. | last2 = Brulport | first2 = M. | last3 = Hermes | first3 = M. | last4 = Oesch | first4 = F. | last5 = De Boer | first5 = D. | last6 = Remião | first6 = F. | last7 = Carvalho | first7 = F. L. | last8 = Schön | first8 = M. R. | last9 = Krebsfaenger | first9 = N. | last10 = Doehmer | first10 = J. | last11 = Bastos Mde | first11 = M. D. L. | last12 = Hengstler | first12 = J. G. | doi = 10.1016/j.tox.2006.10.024 | title = CYP2D6 increases toxicity of the designer drug 4-methylthioamphetamine (4-MTA) | journal = Toxicology | volume = 229 | issue = 3 | pages = 236–244 | year = 2007 | pmid =  17156908| pmc = }}</ref>

 

